The exploration of Parkinson's disease leads to significant findings, particularly the identification of damage in the substantia nigra. Early research, including autopsies, uncovered crucial links between neuronal inclusions and the disease, paving the way for targeted treatments. The synthesis of dopamine in 1910 marked a pivotal moment, shifting the perception of this compound from an unimportant byproduct to a potential key player in addressing Parkinson's symptoms.
